ATE256703T1 - Verfahren zur herstellung eines c1-esterase- inhibitorkonzentrates (c1-inh) und konzentrat zur therapeutischen anwendung - Google Patents

Verfahren zur herstellung eines c1-esterase- inhibitorkonzentrates (c1-inh) und konzentrat zur therapeutischen anwendung

Info

Publication number
ATE256703T1
ATE256703T1 AT95401741T AT95401741T ATE256703T1 AT E256703 T1 ATE256703 T1 AT E256703T1 AT 95401741 T AT95401741 T AT 95401741T AT 95401741 T AT95401741 T AT 95401741T AT E256703 T1 ATE256703 T1 AT E256703T1
Authority
AT
Austria
Prior art keywords
concentrate
inh
esterase inhibitor
producing
therapeutic use
Prior art date
Application number
AT95401741T
Other languages
English (en)
Inventor
Michel Poulle
Nee Radosevich Miryana Burnouf
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465838&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE256703(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aetsrn filed Critical Aetsrn
Application granted granted Critical
Publication of ATE256703T1 publication Critical patent/ATE256703T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT95401741T 1994-07-28 1995-07-24 Verfahren zur herstellung eines c1-esterase- inhibitorkonzentrates (c1-inh) und konzentrat zur therapeutischen anwendung ATE256703T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409353A FR2722992B1 (fr) 1994-07-28 1994-07-28 Procede de preparation d'un concentre d'inhibiteur de la c1-esterase (c1-inh), et concentre obtenu, a usage therapeutique

Publications (1)

Publication Number Publication Date
ATE256703T1 true ATE256703T1 (de) 2004-01-15

Family

ID=9465838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95401741T ATE256703T1 (de) 1994-07-28 1995-07-24 Verfahren zur herstellung eines c1-esterase- inhibitorkonzentrates (c1-inh) und konzentrat zur therapeutischen anwendung

Country Status (11)

Country Link
US (1) US5681750A (de)
EP (1) EP0698616B1 (de)
JP (1) JP3615595B2 (de)
AT (1) ATE256703T1 (de)
AU (1) AU691921B2 (de)
CA (1) CA2154231C (de)
DE (3) DE122011000016I1 (de)
DK (1) DK0698616T3 (de)
ES (1) ES2213155T3 (de)
FR (1) FR2722992B1 (de)
PT (1) PT698616E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4707231B2 (ja) * 1998-06-10 2011-06-22 スタテンズ セーラム インスティテュート マンナン結合レクチンを製造するための精製方法及びmbl医薬品
AT409336B (de) * 1999-12-22 2002-07-25 Baxter Ag Verfahren zur herstellung einer c1-esterase-inhibitor (c1-inh)-hältigen zusammensetzung
RU2256464C1 (ru) * 2004-03-12 2005-07-20 Общество с ограниченной ответственностью "БиоГениус" Способ получения с1-эстеразного ингибитора человека и продукт для использования в медицине
ES2647925T3 (es) * 2011-05-12 2017-12-27 Csl Behring Gmbh Métodos para reducir los eventos adversos causados por preparados farmacéuticos que comprenden proteínas derivadas del plasma
CA3061279A1 (en) 2017-05-16 2018-11-22 Octapharma Ag C1-esterase inhibitor preparation
AU2019361252A1 (en) 2018-10-17 2021-06-03 Csl Behring Gmbh Process for purifying C1-INH
CN114096558B (zh) * 2019-07-04 2024-10-01 德国杰特贝林生物制品有限公司 纯化c1-inh的方法
FR3168764A1 (fr) * 2024-11-28 2026-05-29 Laboratoire Français Du Fractionnement Et Des Biotechnologies Procédé de préparation d'inhibiteur de la C1-estérase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030578A (en) * 1989-07-10 1991-07-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Process for the purification of C1-inhibitor

Also Published As

Publication number Publication date
PT698616E (pt) 2004-04-30
EP0698616B1 (de) 2003-12-17
AU691921B2 (en) 1998-05-28
DE122011000016I1 (de) 2011-12-01
DE122011100064I1 (de) 2012-03-15
DE69532314D1 (de) 2004-01-29
DE69532314T2 (de) 2004-10-21
US5681750A (en) 1997-10-28
EP0698616A1 (de) 1996-02-28
CA2154231C (fr) 2010-02-16
JP3615595B2 (ja) 2005-02-02
CA2154231A1 (fr) 1996-01-29
ES2213155T3 (es) 2004-08-16
JPH08225599A (ja) 1996-09-03
FR2722992A1 (fr) 1996-02-02
AU2496295A (en) 1996-02-08
FR2722992B1 (fr) 1996-10-04
DK0698616T3 (da) 2004-04-19

Similar Documents

Publication Publication Date Title
DE122011100064I1 (de) Verfahren zur Herstellung eines C1-Esterase-Inhibitorkonzentrates (C1-INH) und Konzentrat zur therapeutischen Anwendung.
DE69408870D1 (de) Verfahren zum herstellen von verstärkten ionenaustauschmembranen
DE69431142D1 (de) Zusammensetzungen und Methoden zur Strukturellen Proteinbestimmung
ATE136093T1 (de) Verfahren zur herstellung eines wärmegedämpften glaspaneels und dadurch wärmegedämpftes glaspaneel.
DE69638291D1 (de) Verfahren zur Reinigung von Faktor IX
DE69518497D1 (de) Verfahren zur Herstellung eines Alkohols
ATE199562T1 (de) Verfahren zur herstellung eines styrolpolymeres und darin anwendbarer katalysator
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
EP0168234A3 (en) Purification process for hepatitis surface antigen and product thereof
ATE213252T1 (de) Verfahren zur herstellung eines inter-alpha- trypsin inhibitor konzentrats mit therapeutischer anwendung und so erhaltenes konzentrat
SE8403630D0 (sv) Humana proteiner
DE3668621D1 (de) Verfahren zur herstellung von pteridinderivaten.
DE69613872D1 (de) Herstellung eines Mischkationsorbentmittels in einem Einzeldurchlaufionenaustauschverfahren
ES2105961A1 (es) Procedimiento para la preparacion y purificacion de agentes de contraste yodados.
DE69502675D1 (de) Verfahren zur Herstellung von Bis(Aminomethyl)Cyclohexan
ATE135366T1 (de) Verfahren zur reinigung von interleukin-4
BR8901038A (pt) Processo para isolamento ou purificacao de acidos c14-c24-graxos saturados,preponderantemente metil-ramificados
ATE194342T1 (de) Verfahren zur herstellung von optisch aktivem 3- chinuclidinol
ATE240969T1 (de) VERFAHREN ZUR REINIGUNG VON ßBASICß FIBROBLASTEN WACHSTUMSFAKTOR
PT71750B (de) Verfahren zur regenerierung von ionenaustauschern
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.
ATE62490T1 (de) Verfahren zur reinigung vom humanen tumornekrosefaktor.
DE69118878D1 (de) Verfahren zum Herstellen kohlenstoffarmer Stähle
ATE101041T1 (de) Verfahren zur herstellung eines stabilen faktors viii.
ATE196918T1 (de) Verfahren zur herstellung eines zum färben von kontaktlinsen verwendbaren farbstoffs

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0698616

Country of ref document: EP

EEIH Change in the person of patent owner